| 176 | 1 | 5 |
| Downloads | Citas | Reads |
Objective To analyze the genomic characteristics of Omicron variant strains of local SARS-CoV-2 in Anyang, and provide scientific evidence for understanding the mutation and change regular pattern of novel coronavirus infection in Anyang.Methods The whole genome sequence of the virus was obtained by third-generation nanopore sequencing of oropharyngeal swabs collected from 13 local reported COVID-19 cases in Anyang in November,2022. The virus type was determined by using an online analysis platform. MEGA 11.0 software was used for sequence alignment and analysis; phylogenetic tree was constructed; specific mutation sites were identified, and the molecular characteristics of viruses were analyzed. Results All of the 13 strains were Omicron variants, with sequence lengths of 29 615 nt-29 752 nt, covering 99.1%-99.7%, and a total of 103nucleotide mutation sites and 94 amino acid mutation sites. The mutation sites were distributed in 8 gene coding regions, 5'terminal non-coding region and 3' terminal non-coding region of the novel coronavirus. Among them, the mutation of S protein had the greatest impact on the mutation of the novel coronavirus. R346T and C1243F were the unique amino acid mutation sites of BF.7.14 on S protein; T883I was the amino acid mutation site unique to BA.5.2.49. Q241K was the unique amino acid mutation site of DY.2; the types of the 13 sequences on the Pangolin database were DY.2, BA.5.2.49 and BF.7.14, respectively,and the Nextclade evolutionary analysis was 22B. Phylogenetic tree analysis showed that the 13 SARS-CoV-2 whole genome sequences and reference sequence construction phylogenetic tree were divided into two major branches, namely BF.7 branch and BA.5.2 branch. Conclusions The genomic variation characteristics of the 13 strains of SARS-CoV-2 in this study showed that S protein mutation sites in the gene coding region had the highest number, and there were also protein mutation sites in other regions. The variation sites can be used to analyze the changes of virus transmission ability, immune escape ability and so on;this analysis has accumulated data for continuous monitoring of SARS-CoV-2 genomic variation in the future.
[1]国家卫生健康委员会.公告[EB/OL].[2022-12-26]. http://www. nhc. gov. cn/xcs/zhengcwj/202212/6630916374874368b9fea6c2253289e1.shtml.
[2] ZHU N, ZHANG D, WANG W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J].New England Journal of Medicine,2020,382(8):727-733.
[3] MAJUMDER J, MINKO T. Recent developments on therapeutic and diagnostic approaches for COVID-19[J].The AAPS Journal,2021,23(1):14.
[4]国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(第九版)[EB/OL].[2022-03-14].http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml.
[5] BHAT EA, KHAN J, SAJJAD N, et al. SARS-CoV-2:Insight in genome structure, pathogenesis and viral receptor binding analysis-An updated review[J].International Immunopharmacol,2021,95(63):107493.
[6]黄俊,马学锋,邵慧娟,等.奥密克戎变异株亚型的最新研究进展[J].海南医学院学报,2022,28(13):961-965.
[7]刘晓瑜,魏永伟. SARS-CoV-2 S蛋白:研究进展与挑战[J].病毒学报,2020,36(6):1157-1164.
[8] HULSWIT R, HAAN C, BOSCH B. Coronavirus spike protein and tropism changes[J].Advances in Virus Research,2016(96):29-57.
[9] World Health Organization. Tracking SARS-CoV-2 variants[EB/OL].[2023-03-15].https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
[10]解有成,康殷楠,高春,等.新冠病毒“奥密克戎亚型变异毒株BA.2”的最新研究进展[J].海南医学院学报,2022,28(8):561-565.
[11]张相萍,马红霞,侯自员,等.一例新型冠状病毒奥密克戎BA.2.2.1的全基因组分析[J].现代疾病预防控制,2023,34(5):366-370.
[12] GIOVANETTI M, BENEDETTI F, CAMPISI G, et al. Evolution patterns of SARS-CoV-2:Snapshot on its genome variants[J].Biochemical and Biophysical Research Communications,2021,538(10):88-91.
[13]郭永豪,张延炀,郭万申.新型冠状病毒谱系分类及基因组核酸变异[J].河南预防医学杂志,2021,32(3):161-165.
[14] CAO YL,JIAN FC,WANG J, et al. Imprinted SARS-CoV-2humoral immunity induces convergent Omicron RBD evolution[J]. Nature, 2023,614(7948):521-529.
[15] KOYAMA T, PLATT DE, PARIDA L. Variant analysis of SARS-CoV-2 genomes[J].Bulletin of the World Health Organisation, 2020,98(7):495-504.
[16] ISABEL S, GRAA-MIRAGLIA L, GUTIERREZ JM, et al.Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide[J].Scientific Reports, 2020,10(1):14031.
[17] SEBASTIAN D, LEO F, MELINA HS, et al. Temporal signal and the phylodynamic threshold of SARS-CoV-2[J].Virus Evolution,2020,6(2):veaa061.
[18]国家卫生健康委员会.关于对新型冠状病毒感染实施“乙类乙管”的总体方案[EB/OL].[2022-12-26]. http://www.nhc. gov. cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml.
Basic Information:
DOI:10.13515/j.cnki.hnjpm.1006-8414.2024.03.014
China Classification Code:R373
Citation Information:
[1]BAO Xiaobing,WANG Weiwei,SONG Yun ,et al.Genomic characterization of Omicron variants of local novel coronavirus in Anyang of Henan,2022[J].Modern Disease Control and Prevention,2024,35(03):212-217+236.DOI:10.13515/j.cnki.hnjpm.1006-8414.2024.03.014.
2024-03-19
2024-03-19
2024-03-19